Nitrogen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which necessitate careful consideration and oversight by qualified healthcare professionals. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Administration of Nitrogen should be conducted exclusively by or under the supervision of a licensed practitioner who possesses experience in the use and administration of this gas. The practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

The route of administration for Nitrogen is via respiratory inhalation. The active ingredient is Nitrogen, provided at a concentration of 990 mL in a 1 L container. It is essential that practitioners adhere to established protocols for inhalation to ensure safe and effective delivery of the gas.

Contraindications

Use of this product is contraindicated in individuals who have not read and understood all safety precautions. Handling the product without this knowledge may pose safety risks.

Warnings and Precautions

If inhaled, it is imperative to remove the individual to fresh air and ensure they are comfortable for breathing. Immediate medical advice or attention should be sought in such cases.

General precautions must be observed to ensure safe handling and use. A backflow preventive device should be utilized in the piping to prevent any potential hazards. The valve must be closed after each use and when the cylinder is empty. It is essential to use the product only with equipment that is rated for cylinder pressure. The valve should not be opened until it is securely connected to the appropriate equipment that is prepared for use. Prior to use, it is crucial to read and follow the Safety Data Sheet (SDS) to understand the risks and safety measures associated with the product.

Currently, there are no specific laboratory tests recommended for monitoring during the use of this product. However, healthcare professionals should remain vigilant and prepared to respond to any adverse effects that may arise.

Side Effects

Patients should be aware that the product contains gas under pressure, which may pose serious risks if heated, including the potential for explosion. Additionally, the gas may displace oxygen, leading to rapid suffocation.

In the event of inhalation, it is crucial to remove the individual to fresh air and ensure they are comfortable for breathing. Medical advice or attention should be sought immediately to address any potential complications arising from exposure.

No specific adverse reactions or side effects have been documented in clinical trials or postmarketing experiences beyond the aforementioned warnings.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information regarding the use of Nitrogen in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful monitoring and consideration of individual patient factors. It is advisable to assess the overall health status and any comorbidities of geriatric patients prior to initiating treatment.

Pregnancy

The administration of Nitrogen during pregnancy may pose potential risks to both the pregnant patient and the developing fetus. Due to the potential hazards associated with its use, Nitrogen is contraindicated in pregnant patients unless administered under the supervision of a licensed practitioner experienced in its use.

Healthcare professionals should exercise caution when considering the use of Nitrogen in women of childbearing potential. The risks associated with its administration during pregnancy have not been fully established, and the potential for adverse fetal outcomes necessitates careful evaluation and monitoring. It is imperative that the benefits and risks are thoroughly discussed with the patient prior to administration.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not established. It is advisable to weigh the potential benefits against any unknown risks when considering treatment options for lactating patients.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert for Nitrogen. Healthcare professionals should exercise caution and consider individual patient factors when prescribing this medication to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions in the patient's medical record to ensure continuity of care and facilitate further management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards and is contraindicated in certain situations. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the warning that Nitrogen contains refrigerated gas, which may lead to cryogenic burns or injuries. Additionally, it may displace oxygen, resulting in rapid suffocation. Therefore, patients must not handle Nitrogen until they have read and fully understood all safety precautions.

It is crucial to inform patients that Nitrogen should be used and stored exclusively outdoors or in a well-ventilated area. They should be instructed to wear appropriate protective gear, including cold insulating gloves, a face shield, and eye protection, to minimize the risk of injury.

Patients should also be cautioned against changing or forcing connections, and they must ensure that a backflow preventive device is utilized in the piping. After each use and when the container is empty, the valve should be closed, and the container must always be kept in an upright position.

Healthcare providers should emphasize the importance of reading and following the Safety Data Sheet (SDS) prior to use. In the event of an emergency, patients should be informed of the first aid measures: if Nitrogen is inhaled, they should be removed to fresh air and kept comfortable for breathing. If Nitrogen comes into contact with the skin, they should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical attention. Patients should be advised to seek medical advice or attention if they experience inhalation of Nitrogen.

Storage and Handling

The product is supplied in a container that must be used and stored exclusively outdoors or in a well-ventilated area. It is essential to keep the container in an upright position at all times and to close the valve after each use and when the container is empty.

To ensure safety, the product should be protected from sunlight when the ambient temperature exceeds 52°C (125°F). It is crucial to use the product only with equipment that is rated for cylinder pressure. The valve should not be opened until it is connected to the appropriate equipment that is prepared for use.

Prior to handling the product, it is imperative to read and follow the Safety Data Sheet (SDS) thoroughly. Additionally, a backflow preventive device must be utilized in the piping to maintain safety standards. All safety precautions should be understood and acknowledged before handling the product.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by American Welding & Gas. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)